FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316455979> ?p ?o ?g. }

• W2316455979 endingPage "450" @default.
• W2316455979 startingPage "444" @default.
• W2316455979 abstract "To ascertain the results of standard ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, dacarbazine) in HIV-infected patients with newly diagnosed Hodgkin's disease (HD), a nonrandomized, prospective, multiinstitutional clinical trial was conducted by the AIDS Clinical Trials Group (ACTG), in HIV-infected patients with Hodgkin's disease. All patients received the standard ABVD regimen, with granulocyte-colony-stimulating factor (G-CSF). Antiretroviral therapy was not used. Between May, 1992 and August, 1996, 21 patients were added to the study and treated. The median CD4 count was 113 cells/mm3, and 29% had a history of a clinical AIDS-defining condition before diagnosis of HD. Systemic B symptoms were present in 90% at diagnosis. Stage IV HD was present in 67%, with bone marrow involvement in 12 (57%). Nodular sclerosis HD was present in 38%, with mixed cellular disease in 31%. Among all patients entered and treated, complete remission (CR) was attained in 9 (43%; 90% confidence interval [CI], 24%-63%), whereas partial response occurred in 4 (19%), leading to an overall objective response rate of 62% (90% CI, 42%-79%). Despite routine use of G-CSF, 10 patients (47.6%) experienced life-threatening neutropenia, with absolute neutrophil counts <500 cells/mm3. In all, nine opportunistic infections occurred in 6 patients (29%) during the study or shortly thereafter. Median survival was 1.5 years. Results of this study suggest that alternative treatment strategies should be explored, including use of chemotherapy together with antiretroviral therapy." @default.
• W2316455979 created "2016-06-24" @default.
• W2316455979 creator A5005358222 @default.
• W2316455979 creator A5031767505 @default.
• W2316455979 creator A5052181310 @default.
• W2316455979 creator A5067821687 @default.
• W2316455979 creator A5068289010 @default.
• W2316455979 creator A5073070877 @default.
• W2316455979 creator A5088797767 @default.
• W2316455979 date "2000-08-01" @default.
• W2316455979 modified "2023-10-16" @default.
• W2316455979 title "Chemotherapy Consisting of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine With Granulocyte–Colony-Stimulating Factor in HIV-Infected Patients With Newly Diagnosed Hodgkin's Disease: A Prospective, Multi-institutional AIDS Clinical Trials Group Study (ACTG 149)" @default.
• W2316455979 cites W1757115607 @default.
• W2316455979 cites W1904609393 @default.
• W2316455979 cites W1962101714 @default.
• W2316455979 cites W1967970056 @default.
• W2316455979 cites W1987348395 @default.
• W2316455979 cites W1990723326 @default.
• W2316455979 cites W1997169389 @default.
• W2316455979 cites W2001156688 @default.
• W2316455979 cites W2003446750 @default.
• W2316455979 cites W2037122055 @default.
• W2316455979 cites W2053578889 @default.
• W2316455979 cites W2055310422 @default.
• W2316455979 cites W2059061459 @default.
• W2316455979 cites W2061966524 @default.
• W2316455979 cites W2062023008 @default.
• W2316455979 cites W2064739909 @default.
• W2316455979 cites W2066561342 @default.
• W2316455979 cites W2068518657 @default.
• W2316455979 cites W2075232654 @default.
• W2316455979 cites W2083186736 @default.
• W2316455979 cites W2092916082 @default.
• W2316455979 cites W2100775639 @default.
• W2316455979 cites W2130904233 @default.
• W2316455979 cites W2135347094 @default.
• W2316455979 cites W2155810054 @default.
• W2316455979 cites W2165308914 @default.
• W2316455979 cites W2166792536 @default.
• W2316455979 cites W2207257705 @default.
• W2316455979 cites W2252848026 @default.
• W2316455979 cites W2320902565 @default.
• W2316455979 cites W2325651577 @default.
• W2316455979 cites W2332093328 @default.
• W2316455979 cites W2333394382 @default.
• W2316455979 cites W2339219218 @default.
• W2316455979 cites W2395607120 @default.
• W2316455979 cites W2494592270 @default.
• W2316455979 cites W4211250890 @default.
• W2316455979 cites W4230190426 @default.
• W2316455979 cites W4240794527 @default.
• W2316455979 cites W75569159 @default.
• W2316455979 doi "https://doi.org/10.1097/00126334-200008150-00009" @default.
• W2316455979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11035615" @default.
• W2316455979 hasPublicationYear "2000" @default.
• W2316455979 type Work @default.
• W2316455979 sameAs 2316455979 @default.
• W2316455979 citedByCount "68" @default.
• W2316455979 countsByYear W23164559792012 @default.
• W2316455979 countsByYear W23164559792013 @default.
• W2316455979 countsByYear W23164559792014 @default.
• W2316455979 countsByYear W23164559792015 @default.
• W2316455979 countsByYear W23164559792016 @default.
• W2316455979 countsByYear W23164559792017 @default.
• W2316455979 countsByYear W23164559792018 @default.
• W2316455979 countsByYear W23164559792020 @default.
• W2316455979 countsByYear W23164559792021 @default.
• W2316455979 countsByYear W23164559792022 @default.
• W2316455979 countsByYear W23164559792023 @default.
• W2316455979 crossrefType "journal-article" @default.
• W2316455979 hasAuthorship W2316455979A5005358222 @default.
• W2316455979 hasAuthorship W2316455979A5031767505 @default.
• W2316455979 hasAuthorship W2316455979A5052181310 @default.
• W2316455979 hasAuthorship W2316455979A5067821687 @default.
• W2316455979 hasAuthorship W2316455979A5068289010 @default.
• W2316455979 hasAuthorship W2316455979A5073070877 @default.
• W2316455979 hasAuthorship W2316455979A5088797767 @default.
• W2316455979 hasBestOaLocation W23164559791 @default.
• W2316455979 hasConcept C126322002 @default.
• W2316455979 hasConcept C141071460 @default.
• W2316455979 hasConcept C203014093 @default.
• W2316455979 hasConcept C2776232574 @default.
• W2316455979 hasConcept C2776305933 @default.
• W2316455979 hasConcept C2776694085 @default.
• W2316455979 hasConcept C2776755627 @default.
• W2316455979 hasConcept C2777063308 @default.
• W2316455979 hasConcept C2777132456 @default.
• W2316455979 hasConcept C2778336483 @default.
• W2316455979 hasConcept C2779196057 @default.
• W2316455979 hasConcept C2779429289 @default.
• W2316455979 hasConcept C2780727368 @default.
• W2316455979 hasConcept C2780964509 @default.
• W2316455979 hasConcept C2781413609 @default.
• W2316455979 hasConcept C3013748606 @default.
• W2316455979 hasConcept C535046627 @default.
• W2316455979 hasConcept C71924100 @default.
• W2316455979 hasConcept C90924648 @default.
• W2316455979 hasConceptScore W2316455979C126322002 @default.

• next